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Background: Next-generation sequencing (NGS) of antibody variable regions has emerged as a powerful tool in
systems immunology by providing quantitative molecular information on polyclonal humoral immune responses.
Reproducible and robust information on antibody repertoires is valuable for basic and applied immunology studies:
thus, it is essential to establish the reliability of antibody NGS data.
Results: We isolated RNA from antibody-secreting cells (ASCs) from either 1 mouse or a pool of 9 immunized mice
in order to simulate both normal and high diversity populations. Next, we prepared three technical replicates of
antibody libraries by RT-PCR from each diversity scenario, which were sequenced using the Illumina MiSeq platform
resulting in >106 250 bp paired-end reads per replicate. We then assessed the robustness of antibody repertoire data
based on clonal identification defined by amino acid sequence of either full-length VDJ region or the complementarity
determining region 3 (CDR3). Leveraging modeling approaches adapted from mathematical ecology, we found
that in either diversity scenario both CDR3 and VDJ detection nears completeness indicating deep coverage of
ASC repertoires. Additionally, we defined reliability thresholds for accurate quantification and ranking of CDR3s
and VDJs. Importantly, we show that both factors–(i) replicate sequencing and (ii) sequencing depth–are crucial
for robust CDR3 and VDJ detection and ranking.
Conclusions: In summary, we established widely applicable experimental and computational guidelines for robust
antibody NGS and analysis, which will help advance systems immunology studies related to the quantitative
profiling of antibody responses following infection and vaccination.Background
Antibody-secreting cells (ASCs), plasmablasts and plasma
cells, play a pivotal role in immunological protection, and
thus, are studied intensely in the fields of basic humoral
immunity, vaccine development, and monoclonal antibody
engineering [1-6]. The ensemble of secreted serum anti-
bodies, IgG representing the predominant isotype [7],
constitutes the highly diverse polyclonal antibody repertoire
capable of recognizing and specifically binding to many
different antigens. Primary antibody heavy chain diversity
is achieved by the stochastic rearrangement of three exons
(V, D, and J) [8,9]; additional secondary diversification can* Correspondence: sai.reddy@bsse.ethz.ch
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unless otherwise stated.occur in activated B-cells via somatic hypermutation of
the variable (VDJ) region. Antibody-specificity is believed
to be dominated by the junctional site of VDJ recombin-
ation, also known as the complementarity determining re-
gion 3 (CDR3) [10]. The CDR3 has thus served for a long
time as a natural identifier of antibody clonality. However,
it has recently been suggested that antibody specificity is a
result of the close interplay of different parts of the entire
VDJ region [11,12]; consequentially, the number of reports
relying on the entire VDJ region as clonal identifier is
expanding [4,13-16].
An emerging systems immunology method to quantita-
tively assess the antibody repertoire’s immense diversity
is high-throughput immune repertoire analysis, which
combines next-generation sequencing (NGS), bioinformat-
ics, and statistical analysis of variable regions [17-19]. Intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Greiff et al. BMC Immunology 2014, 15:40 Page 2 of 14
http://www.biomedcentral.com/1471-2172/15/40particular, antibody repertoire NGS has become a power-
ful tool to quantitatively address fundamental questions in
immunology related to lymphocyte development and
differentiation [20], discovery of clinical diagnostics
based on antibody sequence biomarkers [14,21,22], and
antibody repertoire diversity [20,23-25]. One of the
principal advantages of antibody NGS is the quantita-
tive determination of clonal diversity and distribution,
which provides valuable insight into clonal selection
and expansion during humoral responses [26]. This
assessment of clonal diversity and distribution offers
new approaches for vaccine profiling and monoclonal
antibody discovery and engineering [1,4,13,27-31].
Due to current technological limitations, the antibody
repertoire diversity at any given time can at best only be
estimated and not empirically determined in mammals
[32,33]. Therefore, the number of sequencing reads to
accurately and reproducibly represent diversity informa-
tion is unclear [34]. Until recently, NGS using the 454
technology led to read counts in the range of 104–105
[4,35], thus most likely undersampling B-cell and ASC
numbers (>106) in both mice and humans [36-39]. The
advent of the 250 bp paired-end read technology devel-
oped by Illumina offers for the first time the possibility to
assess antibody repertoire diversity by enabling (i) cover-
age of the entire VDJ region and (ii) the generation of
large numbers of reads (>106) at a more practical cost.
Reproducible sequencing of antibody repertoires is of
paramount importance for the development of diagnostic
approaches [40,41]. In light of recent findings that anti-
body clonal abundance is correlated to antigen specificity
[4,42,43], reliable capture of ranking information is neces-
sary for monoclonal antibody discovery and profiling of
antibody responses to vaccines and infections. The con-
cerns of undersampling the antibody repertoire naturally
lead to the following questions [17,40]: (i) To what extent
are antibody clones within one sample being detected
by NGS? (ii) What percentage of detected clones can be
reliably and reproducibly identified? (iii) To what extent
do reliably detected clones bear accurate frequency in-
formation (Figure 1A)?
For the statistical analysis of antibody NGS datasets,
we leveraged long-established concepts of ecological
population theory, which have only recently been ap-
plied to immunoglobulin repertoire diversity [14,23,44-49].
We found that regarding murine IgG-positive ASC
repertoire sequencing approximately ≈ 3×106 250 bp
paired-end reads were sufficient to capture their essen-
tial diversity information–i.e. number of different
clones and their respective clonal frequency–of CDR3s
and full-length VDJ regions alike. Triplicate sequen-
cing enabled us to efficiently call reliably detected
clones as well as define a threshold for reliable clonal
ranking.This study establishes that NGS of antibody repertoires
of immunized mice is a robust technique for exploring
questions of fundamental immunological importance such
as antibody diversity in response to antigen-challenge.
Finally, we offer experimental and computational guide-
lines for faithful antibody NGS that are independent of
model organism, immunization scheme, and target cell
population.
Results
High quality Illumina triplicate sequencing of
antibody-secreting cells from pooled and
individual mouse samples
Two scenarios of immunological relevance were assessed
for NGS reproducibility. First, we pooled spleen plasma-
blasts and plasma cells (CD138-enriched) and bone mar-
row plasma cells (CD45R-depleted and CD138-enriched
[4,50]) of one mouse immunized with the model antigen
NP-CGG (chicken gamma globulin [CGG] conjugated to
4-hydroxy-3-nitrophenylacetyl) and sacrificed 14 days
post-immunization, hereafter called “1M”. The thus cre-
ated cell pool contained approximately 3×106 viable ASCs.
Second, in order to model extreme antibody diversity, we
repeated the same cell isolation procedure from nine
immunized mice (hereafter called “9M”) resulting in an
ASC pool of approximately 2.5×107 viable cells (Figure 1B).
From isolated cells, we recovered total RNA and used
RT-PCR to amplify expressed rearranged IgG variable
heavy genes. PCR was performed using a well-characterized
and utilized primer set based on variable framework
region 1 binding forward primers and one IgG constant
heavy region 1 reverse primer (covering all IgG isotypes,
Additional file 1 [51]). Similarly to previously published
methods [52,53], Illumina adapters were added during
the PCR step by using a direct addition approach, which
adds adapters at the 5′ end of the gene-specific primer
set, thus circumventing the need for ligation of adapters
following PCR (Additional file 2). For each of the two
diversity scenarios (1M/9M), triplicates were prepared,
where a triplicate signifies three separately indexed sam-
ples prepared from the same starting cDNA pool; thus,
variable region PCR amplification was independently
performed in each of the triplicates (see Methods). All
six samples (triplicates of 1M and 9M) were sequenced
using the Illumina MiSeq platform with 250 bp paired-
end reads (Figure 1B). Sequencing yielded an average of
3.2×106 raw reads (paired-end, 250 bp) for each replicate
with mean quality Phred scores ranging from 33 to 36
(Additional file 3).
Sequences were processed (pairing rates of raw 250 bp
reads reached an average of ≈ 92%, Additional file 3) and
submitted to the open-access ImMunoGeneTics (IMGT)/
HighV-Quest platform [54] in order to obtain full-length
VDJ region and CDR3 read annotation.
Figure 1 Motivation and experimental setup. (A) The problem of undersampling in NGS antibody repertoire sequencing is most easily
explained by the marble analogy. Assuming an urn is filled with k numbers of marbles of different species in varying frequencies–urn and
marbles represent the original antibody mixture. The problem is clear: if only a sample of size n (n < k) is drawn, then three qualitatively different
sampling outcomes can arise: (1) If n is too small, species richness (number of different colors in the urn) is not accurately determined and
consequently neither are species frequencies. (2) In the case that n is larger, species richness is accurately represented but species frequencies
can be off. (3) Only if n is large enough, both species richness and frequency are accurately reflected in the sample. This study set out to answer,
which outcome best describes antibody repertoire NGS data from ASCs of immunized mice. (B) To address undersampling concerns, we
explored two different scenarios of ASC diversity: 10 female BALB/c mice were immunized with NP-CGG and sacrificed 14 days post-injection.
Subsequently, bone marrow plasma cells were isolated as described previously, as were CD138-positive splenocytes [4]. ASCs of 1 mouse (1M)
were pooled as were those of 9 mice (9M). RNA was isolated, followed by RT-PCR and Illumina MiSeq sequencing of triplicates (see Methods).
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inflate diversity, all CDR3 and VDJ singletons (CDR3 and
VDJ amino acid sequences that only occurred once)
were excluded prior to any data analysis, as were any
reads with CDR3s shorter than 4 amino acids. The average
number of thus filtered CDR3s and VDJs for 1M/9M were
respectively ≈ 1.1×106/≈1.7×106 (unique: ≈14,000/≈30,000)
and ≈ 740,000/≈1.0×106 (unique: ≈54,000/≈112,000), which
still represented approximately ≈ 95% and ≈ 61% of pre-
filtered CDR3 and VDJ sequences respectively (Additional
file 3).
Antibody repertoire sequencing achieves deep coverage
of CDR3 clonal diversity
Throughout the entire study, we defined antibody
clonality in two ways: (i) based on identical amino acid
sequence of variable heavy chain CDR3 (based on IMGT
classification); (ii) based on identical amino acid sequence
of full-length heavy chain VDJ region. We focused on the
analysis of the heavy chain because it contributes predom-
inantly to antibody diversity and specificity [10].
Frequency distributions of CDR3s and VDJs differed
markedly from one another. For each of the diversity
scenarios (1M/9M), frequency distributions of VDJs
were less polarized than CDR3s (Additional file 4)
since for any sample the number of unique VDJs was much
higher than the number of unique CDR3s (Additional
file 3). Due to an increased CDR3 and VDJ diversity in
9M replicates, cumulative frequency curves saturated
faster for 1M than for 9M; this was especially evident
for CDR3s (Additional file 5).
Since comparison across replicates depends on their
deep coverage, we first addressed the issue of under-
sampling. To do so, we relied on simulations that used
a sequential sampling scheme (bootstrapping) for both
CDR3 and VDJ clonal distributions. Simulations were
performed for one replicate dataset from the 1M and
9M triplicates. The replicate that was chosen was based
on having the unfavorably highest ratio of different CDR3s
to total CDR3s. We performed a bootstrapping ap-
proach with 1,000 equally sized sampling steps, where
in each step a random set of CDR3/VDJ sequences
(from the replicate NGS dataset) was added to virtual
samples. Sampling steps continued until virtual samples
had accumulated the same number of sequences as the
starting replicate (Figure 2).
On the basis of these simulations, we sought to plot
species accumulation curves, which were determined by
calculating the proportion of simulation runs that
added new CDR3/VDJ sequences to the virtual samples
(Figure 2A). An undersampling issue would be present
in samples if new clones were still added at 100% of ac-
cumulated sequences [34,45]. However, we found that
for both CDR3 and VDJ and both diversity scenarios(1M/9M) the probability of obtaining a new clone nears
zero for read accumulation rates ranging between 75%
and 100% (Figure 2A). We therefore concluded that reper-
toire NGS of murine antibody producing cells achieves
high coverage of clonal diversity and is not substantially
influenced by undersampling.
Complementing species accumulation curves, we also
plotted the median species richness of the simulation
runs (Figure 2B). Species richness signifies the number
of different CDR3/VDJ sequences. Species richness curves
of both CDR3s and VDJs leveled off toward 75% of accu-
mulated reads indicating that 75% of the sequences would
have been enough to accurately represent a replicate’s
species richness.
Lastly, to study how frequency-dependent diversity
depends on read accumulation, we assessed the change
of the effective number of species as a function of accu-
mulated reads. The effective number of species (ENS) is
the exponential of the Shannon entropy, which is a
widely used measure of repertoire diversity [44,55]. If all
clones are equally abundant, then the ENS is high, tending
towards the species richness. Conversely, if one clone
dominates the repertoire, then the ENS is low, tending
towards 1 [46,55]. In addition to including species
richness, the ENS also takes CDR3/VDJ frequencies into
account. For CDR3s, nearly the entire ENS information
was captured at only 25% of accumulated sequences,
whereas for VDJ it required nearly 75% of accumulated
sequences for complete ENS coverage (Figure 2C). Curves
of 1M leveled off slightly faster than 9M curves.
To summarize, we found that independently of clonal
definition, diversity scenario, and statistical method,
diversity information was captured at or below 100%
read accumulation. In particular, the number of reads
needed to exhaustively cover antibody repertoire diversity
was considerably reduced if CDR3/VDJ frequency infor-
mation was taken into consideration.
Replicate sequencing enables reliable detection of
antibody clones
Leveraging the deep repertoire coverage, we proceeded by
establishing a cutoff, which ensures that 99% of clones
in a given replicate would be found in the two other
replicates (Figure 3). Resulting from this reliable detec-
tion cutoff, for 1M triplicates, the top 1427, 862 and
791 CDR3s and for 9M triplicates, the top 9414, 9485
and 9460 CDR3s were found to be reliably detected
(Figure 3, Additional file 6). Accordingly, the numbers
of reliably detected VDJs for 1M were 10741, 10731 and
11055 and for 9M 18765, 18928 and 18466 (Figure 3,
Additional files 3 and 6). The reliably detected CDR3/VDJ
clones for each replicate were used in all analyses shown
hereafter. Thus, replicate sequencing provided a powerful
method to establish reliability of clonal detection.
A B C
Figure 2 Diversity information was captured for all CDR3 and VDJ clones with an abundance of two or more regardless of ASC
diversity (1M/9M). To address undersampling, we used a sequential sampling scheme (bootstrapping) in which CDR3 and VDJ datasets were
divided into 1,000 read subsets, which were successively added to virtual samples until they had the same size as the original samples. We
performed 200 simulation runs for one sample of each diversity scenario (1M/9M) having the highest ratio of different CDR3 clones to total
numbers of CDR3s. Graphs show (A) the percentage of simulation runs with newly seen CDR3/VDJ clones in a given subset; (B) the normalized
median CDR3/VDJ species richness; (C) normalized effective number of CDR3/VDJ species, where “normalized” signifies the division by the
respective maximal value.
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Due to the high importance of reliable clonal ranking
for antibody discovery and vaccination studies [4],
clonal CDR3/VDJ frequencies were converted to ranks
to check for reproducibility across triplicates. TheFigure 3 Establishing a cut-off for reliable clonal detection. For each rep
were tested for their simultaneous presence in the respective two other replic
were recorded. We regarded all those clones as “reliably detected” that belon
absence ≥99%. The percentage of clones passing the detection threshold is i
clones for CDR3-1M were (1427, 862, 791), and for CDR3-9M were (9414, 9485
11055) and (18765, 18928, 18466), respectively. For a graphical overview of thhighest rank was attributed to the CDR3/VDJ identical
amino acid sequence with the highest frequency, the
second highest rank to the CDR3/VDJ with the second
highest frequency and so forth. Rank-converted tripli-
cates were Pearson correlated in a pairwise fashion,licate (A: CDR3, B: VDJ), starting with the highest frequency clones, clones
ates. For each clone, presence or absence in the other two replicates
ged to the highest frequency set of clones with a ratio of presence to
ndicated by vertical red bars. Absolute numbers of reliably detected
, 9460). For VDJ, 1M and 9M absolute numbers were (10741, 10731,
e method of reliable detection, please refer to Menzel et al. [53].
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(range: r = 0.94–0.98, p < 0.001) and VDJ correlation
coefficients of r > 0.74 (range: r = 0.75–0.89, p < 0.001)
for both diversity scenarios (1M/9M) (Figure 4).
Accordingly, correlations between triplicates based on
CDR3 and VDJ frequencies had very high coefficientsFigure 4 Correlation of ranks of CDR3 and VDJ sequences between re
reproducibility of antibody repertoire sequencing. The ranks of CDR3 (
assigning the highest rank to the CDR3 or VDJ sequence with the highest
with the second highest abundance and so forth. Association of ranks was
correlation plots are displayed using hexagons–purple indicates where dat
(Figure 3) were considered for the analysis shown.(r > 0.98 for both 1M and 9M, Additional file 7). Q-Q
plots also showed that in addition to ranking and
frequency, clonal distributions were highly reprodu-
cible, thereby emphasizing the high fidelity of Illumina
MiSeq-generated antibody NGS data (Additional files
8 and 9).plicates is high (CDR3: r ≥ 0.94, VDJ: r ≥ 0.75) demonstrating
A: 1M, B: 9M) and VDJ (C: 1M, D: 9M) sequences were determined by
abundance, the second highest rank to the CDR3 or VDJ sequence
determined using Pearson correlation (r). To circumvent overplotting,
a points accumulate. Only reliably detected CDR3 and VDJ sequences
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reliable ranking of antibody clones
In light of previous research demonstrating a correlation
between clonal ranking and specificity [4], we assessed
the reliability of ranking as a function of sequence cover-
age. We defined reliability of ranking information as the
coefficient of variation (CV = SD/mean) of CDR3/VDJ
ranks across triplicates. Hence, in contrast to pairwise
correlation coefficients, reliability of ranking information
took advantage of all three replicates for a given diversity
scenario. We deemed the rank of a CDR3/VDJ reliable if
its CV was below 0.05, which we used as a reliability
cutoff (Additional file 10). Similarly to Figure 2, we used
a sequential sampling scheme to assess the dependence
of sequencing depth on rank reliability by calculating the
ratio of the number of reliably ranked CDR3s/VDJs to
the number of reliably detected CDR3s/VDJs as a function
of accumulated reads. Simulations showed that the
maximum ratio of reliably ranked sequences was achieved
at ≈ 25% of accumulated reads for both definitions of
clonality (CDR3/VDJ) and both diversity spectra (1M/9M,
Figure 5). Ratios of reliably ranked clones are positively
proportional to the number of different clones found per
number of reads reaching a maximum of ≈ 50% for
CDR3-1M and a minimum of ≈ 21% for VDJ-9M (Figure 5,
Additional file 10). Thus, with increasing CDR3/VDJ
diversity, the percentage of reproducibly detected clones
that can be reliably ranked decreases.
In summary, triplicate sequencing does not only enable
reliable calling but also ranking of antibody clones:A
Figure 5 Reliable ranking of (A) CDR3 and (B) VDJ sequences depend
reliably ranked clones–expressed as the median number of clones having a
reliably detected clones determined in Figure 3 as a function of the propo
ratios (displayed as points) in order to extrapolate their overall distribution
increases, the maximum value of the ratio decreases. Across diversity scena
maximum is reached at 25% of accumulated reads. Simulations were perfo
sampling scheme (bootstrapping). The CV was calculated based on ranks o
ranked clones were: CDR3: 730 (1M), 4160 (9M); VDJ: 3708 (1M), 5169 (9M).notably, we show that both factors–(i) replicate
sequencing and (ii) sequencing depth–are important
for a high reliability of clonal detection and ranking.
Discussion
NGS of antibody variable region repertoires has begun
to make a major impact on the emerging field of systems
immunology by providing a quantitative assessment of
humoral immune responses. In this study, we assessed
in great detail the robustness and reproducibility of NGS
antibody amplicon data in a common experimental setting.
To render our results relevant to a wide range of research
groups, we used the common experimental setting of
spleen and bone marrow ASC from immunized mice.
ASCs are of great immunological interest [5,7,56-61] as
they represent the effector cell population of the humoral
immune system producing the vast majority of circulating
IgG antibodies, which are responsible for immediate and
long-term protection against pathogens [56,57]. Experi-
mentally, we adapted previously established methods for
ASC isolation and generation of antibody libraries for
NGS [4,13,52,53]. As a result of recent improvements in
read length of the Illumina MiSeq platform, we were
able to sequence full-length VDJ regions. These im-
provements in sequencing technology were critical for
the execution of this study and are increasingly being
adopted for repertoire sequencing [14,62,63]. For data
analysis, we used statistical approaches that have been
first developed in ecological sciences [64,65] but could
be readily transferred to NGS, as questions regardingB
s on deep sequence coverage of samples. Plots show the ratio of
rank coefficient of variation (CV) lower than 0.05–to the number of
rtion of accumulated reads. A LOESS curve was fitted to the calculated
with a 0.95 confidence interval (gray-shaded area). As species richness
rios (1M/9M) and clonal definitions (CDR3/VDJ) the respective
rmed analogously to those shown in Figure 2 using a sequential
f CDR3/VDJ clones across triplicates. Absolute numbers of reliably
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in both disciplines. These approaches have been re-
cently applied to B- and T-cell repertoire analyses by
other groups [14,44,45,66].
Specifically, our strategy consisted of using mouse
ASC populations after primary immunization from both
normal diversity (1M) and a high diversity (9M) scenario
to quantify clonal diversity and distributions of CDR3
and VDJ amino acid sequences. We isolated ≈ 3×106
ASCs in the 1M sample and ≈ 2.5×107 ASCs in the 9M
sample by magnetic bead-enrichment (Figure 1). Since
only ≈ 30–50% of these cells are estimated to be IgG-
positive [67], the sequencing pool had an estimated size
of 1×106 and 7×106 for 1M and 9M, respectively. The
high diversity 9M scenario led to a less polarized distri-
bution of CDR3s and VDJs compared to 1M (Additional
files 3, 4, and 5). Importantly, the overlap between 1M
and 9M datasets was marginal suggesting minimal or no
contamination across samples (Additional file 6). Bio-
logically interpreted, the small overlap between 1M and
9M datasets (Additional file 6) suggests that the anti-
body repertoires of the inbred mice immunized with a
medium-complexity antigen (NP-CGG) contained few
shared clones. The small overlap of expressed antibody
repertoires between individuals existing in a rather con-
trolled environment has been previously shown by others
[23], including genetically identical immunized mice of
the same cohort [4]. Therefore, the 9M sample mirrored
in fact a highly diverse antibody repertoire.
Our analysis revealed the following major points: (i)
With an average of ≈ 3×106 250 bp reads per replicate,
antibody repertoire NGS provided deep sequence cover-
age over a wide diversity range (1M/9M) with respect to
multiple definitions of clonality (CDR3 or full-length
VDJ amino acid sequence); (ii) leveraging the deep rep-
ertoire coverage and the sequenced triplicates allowed
for the establishment of unambiguous reliability cutoffs
for clonal detection; (iii) down-stream analysis with reli-
ably detected clones demonstrated the reproducibility of
both clonal detection and clonal frequency distributions;
(iv) the reliability of CDR3/VDJ ranking (ranking being
one of the chief indicators of antigen-specificity [4,43])
was not achieved to the same extent as clonal detection.
Furthermore, the percentage of reproducibly detectable
CDR3s that can at the same time be reliably ranked de-
creased as clonal diversity increased (Additional files 3
and 9) supporting the intuitive result that more diverse
samples require greater sequencing depth for sufficient
coverage.
We obtained reliable ranking information for approxi-
mately 21–50% (1M/9M) of the reliably detected CDR3
and VDJ species richness (Figures 3 and 5). These ac-
curately ranked sequences may be very valuable for
monitoring the clonal selection and expansion thattakes place following vaccination or primary infection.
To further increase the resolution of clonal ranking, a
dramatically increased number of reads would be ne-
cessary. Assuming both a constant number of reliably
detected clones and a linear relationship between the
number of reliably ranked clones and sequencing
depth, two (51%, CDR3-1M, Figure 5A) to five (19%,
VDJ-1M, Figure 5B) times more reads would be necessary
to reliably rank all reliably detected clones. Indeed, Toung
and colleagues report that regarding RNA-sequence ana-
lyses of human B-cells, a five times higher read coverage is
necessary to accurately represent frequencies of reliably
detected transcripts [20,68,69]. However, the above es-
timations should be regarded as lower bounds, as with
increasing sequencing depth the number of reliably
detected clones increases (until reaching a maximum)
and the relation between sequencing depth and ranking
information is of non-linear nature. In fact, the impact of
undersampling on ranking accuracy may in part explain
why frequency-based discovery of antigen-specific mono-
clonal antibodies was successful when applied to polarized
bone marrow plasma cells from immunized mice [4] but
was unsuccessful when applied to the less polarized total
splenocyte population from immunized rabbits [31].
Recently, Vollmers and colleagues, performed NGS of
human B-cell repertoires from vaccinated patients, in
which they used RNA template-barcoding to decrease
errors introduced during PCR and Illumina sequencing
[13]. Their approach dramatically reduced false positive
species richness and especially eliminated to a large part
singletons–which we found comprised 73–85% of unique
sequences depending on the clonal definition–suggesting
that our singletons are mostly due to sequencing error. In
agreement with procedures adopted by other groups
[13,70], singletons were thus rightly eliminated from any
data analysis conducted in this report without dramatically
reducing the overall size of the datasets (Additional file 9).
In addition, we showed that removal of singletons does
not substantially impact ENS (increasing CDR3 species
richness from 25% read accumulation onward in Figure 2B
does not entail an increase in ENS in Figure 2C). However,
it should be noted that in cases of very low coverage or
read depth the removal of singletons may artificially
decrease diversity. Apart from technological limitations, the
biological significance of very rare sequences is unclear and
remains to be elucidated [71].
While first and foremost our findings are valid for
murine ASCs collected from a specific mouse strain
immunized once with a single antigen, implications re-
garding the dependence of the completeness of species
richness and frequency information on ASC diversity
can be readily transferred to many other antibody reper-
toire sequencing studies. From the above conclusions, a
generally valid framework in form of practical guidelines
Greiff et al. BMC Immunology 2014, 15:40 Page 9 of 14
http://www.biomedcentral.com/1471-2172/15/40for the analysis and reliable information extraction from
antibody NGS datasets emerges. (i) Immunized mice can
be sequenced with deep coverage yielding–in any diversity
scenario–reliable detection and ranking of a minimum of
at least 20% of reliably detected clones (both CDR3 and
VDJ, 1M/9M). This represents a higher number of candi-
date (reliably detected and ranked) clones than previously
published [4,43]. Importantly, the concept of reliable de-
tection scales with the available sequencing depth; higher
sequencing depth will result in higher numbers of reliably
detected clones. Indeed, Figures 3 and 5 provide a direct
assessment of the relation of sequencing depth and the
extent to which reliable sequencing and ranking can be
established. More generally, by providing NGS data for
two definitions of antibody clonality in two different
diversity scenarios, we provided benchmark and orien-
tation values thus guiding NGS studies performed with
other cell populations and/or other species, accordingly.
(ii) If one desires to perform robust antibody repertoire
NGS, it is advantageous (and now affordable) to perform
replicates per condition (e.g., “healthy”, “immunized”) in
order to set thresholds of reliability for both CDR3 detec-
tion and ranking. It is reassuring that replicate sequencing
is sufficient to achieve high reliability in antibody NGS in
the presence of both PCR error and Illumina sequencing
error. Indeed, it has been shown recently that the number
of replicate samples significantly improves detection
power–even more so than sequencing depth [72,73].
(iii) Statistical methods borrowed from theoretical ecology
are especially useful if facing samples with unknown diver-
sity, which is to this date still the case for all antibody
NGS studies but especially pronounced in repertoire ana-
lyses of non-FACS-sorted human PBMC B-cell populations
[13,43]. Importantly, diversity measures incorporating fre-
quency information saturate faster for a given number
of reads (Figure 2C), allowing for meaningful diversity
comparisons across samples even in the case of limited
read numbers. Nevertheless, we believe that the issue
of biological undersampling in human samples still
poses a challenge deserving further attention, as due to
practical and ethical reasons it is typically only possible
to obtain small fractions of human B-cells (usually from
PBMCs), which thus may not accurately represent the
overall humoral immune status [17,40].
Recently, mRNA/cDNA barcoding using unique mol-
ecule identifiers (UMIs) [74-77] has been used for error
correction in immune repertoire NGS studies [13]. How-
ever, the extent to which the use of UMIs reproducibly
decreases technological noise and increases the recovery
of biological information is as of yet unknown [78].
Studies involving UMIs are dependent on the deep cover-
age of UMI diversity to ensure meaningful consensus-read
formation [13,63]; UMI diversity is introduced via degen-
erate nucleotide regions within reverse transcription (andfirst-strand synthesis) primers, which itself may be a
source of bias [52]. Therefore, UMI studies face potential
PCR bias and undersampling problems both on the clonal
and UMI-tagging level. Our above formulated framework
does not assume any prior knowledge on sample prep-
aration and is thus independent of experimental (e.g.
RNA/DNA barcoding) and bioinformatical pre-processing
steps. Therefore, the framework’s guidelines may be read-
ily applied to studies incorporating UMI data correction
and to further increase quantitation and reproducibility.
Applying statistico-ecological methods to UMI-tagged
datasets would allow crucial insight into the relation of
sequencing depth and the extent of error correction.
As of yet, subjective sequence cutoffs have been used to re-
duce the influence of technological noise on cross-sample
comparisons [13]. In contrast, our concept of reliable de-
tection and ranking relies on the explicit exploitation of
replicate sequencing: it yields a list of reliably detected
clones, which collectively define an unbiased range of
detection reliability (e.g. CDR3 sequences 1–1427, 1M,
Figure 3A). Therefore, our framework offers the possibility
to be applied to all immunoglobulin (antibody or TCR)
NGS studies, including those relying on UMIs as an add-
itional step for error correction in order to determine
upper and lower bounds of reliable detection and ranking.
The definition of ranges of reliable detection and ranking
may be valuable for drug and vaccine development [72].
Conclusions
The ability to robustly detect and rank antibody sequences
is highly valuable for future investigations in systems
immunology; specifically those in which accurate clonal
diversity and distributions are critical such as in infec-
tion or vaccination studies [13,28,79-81]. Now that anti-
body diversity information is being captured at a deep
level, studies setting out to define antibody signatures of
health and disease [21,82] are justified as are studies
taking advantage of diversity measures to compare anti-
body diversity across individuals [28].
Methods
Mouse immunizations
All animal experiments were performed under the guide-
lines and protocols approved by the Basel-Stadt cantonal
veterinary office (Basel-Stadt Kantonales Veterinäramt
Tierversuchsbewilligung #2582). Female BALB/c mice
(n = 10, Charles Rivers Laboratories) 6–8 weeks old were
housed under specific pathogen-free conditions and were
maintained on a normal chow diet.
Purified chicken gamma globulin (CGG) conjugated to
4-hydroxy-3-nitrophenylacetyl (NP, NP-CGG, BioCat) was
resuspended in sterile-filtered phosphate buffered saline
(PBS) at 1.0 mg/mL. On the day of primary immunization,
50 μl of NP-CGG solution was mixed with 100 μL of
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PBS and stored on ice. The NP-CGG Alum mixture was
injected with a 26-gauge needle subcutaneously into the
backpad. Mice were sacrificed on day 14 after primary
immunization and blood, spleen, and bone marrow (fem-
ora and tibiae) were collected.
Cell isolation
Single cell suspensions from total spleen and bone
marrow were obtained as described previously [4].
Briefly, tibiae, femora, and spleens were collected into
RPMI supplemented with 10% fetal bovine serum (FBS,
Sigma, medium 1). Bone marrow cells were flushed out
using a 26-gauge syringe (Braun) and spleens were disinte-
grated using syringe and forceps. Cells were filtered
through a 70-μm cell strainer (BD) and subsequently cen-
trifuged at 1,500 rpm for 10 min at 4°C. Red blood cells
were lysed for 3 min in red blood cell lysis buffer
(eBioscience). The cell suspension was then washed once
with 10 mL medium 1. Finally, cells were resuspended in
1 mL PBS supplemented with 0.5% bovine serum albumin
(BSA) and 2 mM ethylenediaminetetraacetic acid (EDTA,
buffer 1). Bone marrow cells were depleted of CD45R-
positive cells before plasma cell isolation by incubation
with anti-CD45R-biotin antibody (eBioscience, 13-0452)
for 15 min on ice. After washing the cell suspension
twice in BSA-free PBS supplemented with 2 mM EDTA
(buffer 2), 30 μL of washed streptavidin-coupled Dyna-
beads (M-280, Invitrogen) were added and incubated
for 20 min on ice. Following magnetic isolation, the
negative fraction was used in the subsequent steps.
For plasma cell enrichment, spleen and CD45R-depleted
bone marrow cell fractions were incubated with anti-
CD138-biotin antibody (BD, 553713) for 15 min on ice.
Following two washing steps in buffer 1, 30 μL of
Dynabeads were added and incubated for 20 min on ice
as before. Bead-bound cells were manually counted on a
cell counter (Neubauer), buffer removed by magnetic sep-
aration, and beads plus cells were lysed in 1 mL of TRIzol
reagent (Invitrogen) and stored at -80°C until further
usage. Following cell isolation, isolated spleen and bone mar-
row ASCs were combined from nine mice (9M, ≈2.5×107
total ASCs) and one mouse (1M, ≈3×106 total ASCs)
samples.
Preparation of IgG genes ready-to-use for next-generation
sequencing
Total RNA was extracted using the PureLink RNA Mini
Kit (Life Technologies), according to the manufacturer’s
protocol. RNA concentration was measured on a Nano-
drop 2000c Spectrophotometer and RNA integrity and
concentration were further evaluated on a 2100 Bioana-
lyzer (Agilent Technologies). Isolated ASC RNA from
the single mouse and the 9 mice was homogeneouslypooled, aliquoted and frozen together at -80°C. Next,
cDNA of total mRNA was prepared with half of the total
9M RNA and total 1M RNA using Maxima Reverse
Transcriptase (Fermentas) and Oligo(dT) primers (Thermo
Scientific) and following the manufacturer’s protocol. For
each individual reaction, 500 ng RNA was used, cDNA
from multiple reactions were pooled and stored at -80°C.
PCR amplification of the variable heavy IgG genes was
performed with a set of 19 forward primers binding in
the framework region 1 of the VDJ region as previously
described [4,51,53] (Additional file 1) and an IgG-specific
reverse primer binding in the constant heavy region 1
(5′ CARKGGATRRRCHGATGGGG 3′). The Illumina
TruSeq universal adapter sequence constituted the 5′
portion of the forward primers, while the IgG-reverse
primer contained the Illumina index adapter sequence,
thereby directly adding Illumina adapter sequences to
PCR products (Additional file 2). As cell populations
(1M and 9M) were sequenced in triplicates, each PCR
sample was prepared with its own unique index primer.
As previously described [4], each 50 μL PCR reaction
consisted of 0.2 μM of forward primer mix and reverse
primer, 5 μL of Thermopol reaction buffer (NEB), 200
μM dNTPs, 2 μL of unpurified cDNA, 0.25 μL Taq
DNA polymerase (NEB) filled up with double-distilled
water. For each separately indexed sample 10 PCR reac-
tions were run in parallel as follows: 95°C for 3 min; 4
cycles (95°C for 30 sec, 50°C for 30 sec, 68°C for 1 min);
4 cycles (95°C for 30 sec, 55°C for 30 sec, 68°C for 1
min); 20 cycles (95°C for 30 sec, 63°C for 30 sec, 68°C
for 1 min); 68°C for 7 min; 4°C storage. PCR clean-up
was performed in order to reduce the volume and prod-
ucts were run on a 1% agarose gel for purification.
Bands of ≈ 550 bp were gel-excised (Additional file 11),
purified and libraries were submitted for a final quality
control step on a Bioanalyzer 2100 (Agilent, Additional
file 12) prior to sequencing.
Sequencing methods
Read libraries were obtained by 250 bp paired-end sequen-
cing on the Illumina MiSeq platform and can be accessed
from the European Nucleotide Archive (http://www.ebi.ac.
uk/ena, ENA Study Accession: ERP003950).
MiSeq forward and reverse reads were paired using
PANDAseq [83] with default parameters. Successfully
paired sequences were sent to IMGT/HighV-Quest [54]
for annotation of CDR3 and full-length VDJ regions. For
downstream analyses, only those sequences were kept in
which (i) the CDR3 and VDJ region could be detected
by IMGT and (ii) of which CDR3s were of minimal
length of 4 amino acids. Exclusively, CDR3 and VDJ
regions with a minimal abundance of 2 read counts
were used for downstream analyses unless mentioned
otherwise (Additional file 3). CDR3 and VDJ abundance
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Statistics
Association between variables was tested by Pearson
correlation unless mentioned otherwise. P-values below
0.05 were regarded as significant.
Simulations
Bootstrapping was performed using a sequential sampling
scheme in which CDR3/VDJ clones were sequentially
added to virtual samples (the number of virtual samples
being equivalent to the number of simulations performed)
to then determine curves of species accumulation, species
richness, and effective number of species.
Diversity measure calculations
Species richness was calculated as the number of different
(unique) CDR3/VDJ clones in a dataset. The effective





calculated as the exponential of the Shannon entropy of a
given frequency distribution as described previously [55],
where pi is the frequency of the ith CDR3/VDJ and n is
the total number of unique CDR3s/VDJs. The ENS ranges
from 1, in a sample with only one clone (or a highly dom-
inating clone), to n, the total number of unique clones.
For entropy calculations, the natural logarithm was used.
Normalized measures (Figure 2) were calculated by divid-
ing by the maximum respective value, i.e. the respective
value at 100% sequence accumulation.
As a measure of polarization of the ASC repertoire, we
chose the Berger-Parker index [84]. It is calculated as
the ratio of Nmax/N, where Nmax is the abundance of the
top CDR3/VDJ sequence and N the sum of abundances
of all CDR3/VDJ in a replicate.
Software
Starting from IMGT output obtained, data analyses
were performed using the R statistical programming
environment [85]. Non-base R packages used for ana-
lyses were: ggplot2 [86], VennDiagram [87], ShortRead
[88], and hexbin [89].
Additional files
Additional file 1: Primer list for the amplification of full-length IgG
variable regions. 19 partly degenerate forward primers specific for
framework region 1 of the variable heavy chain were used together with a
reverse primer specific for all IgG subclasses. TruSeq universal and index
adapter sequences are 5′ of gene-specific regions, allowing for simultaneous
variable heavy gene amplification and preparation for Illumina NGS. Illumina
diversity regions (5′ of gene-specific regions) were needed by the Illumina
software for reliable cluster calling.
Additional file 2: Primer design for IgG heavy chain amplification
allowing simultaneously direct addition of Illumina sequencingadapters. Forward primers were adapted from Krebber and colleagues
[51]. (A) The forward primer mix, consisting of 19 (partially) degenerate
primers, binds in the framework region 1 of the VDJ region, while the
unique reverse primer binds specifically in the IgG constant heavy region
1. All primers contain a sequence of 4 random nucleotides (termed
diversity region), which was necessary for cluster identification on the
Illumina chip. All forward primers contained the Illumina universal
adapter and the reverse primer contained the reverse complement of a
given index adapter, which enabled multiplexed sequencing. (B) Primer
design and binding to the variable (V) region (framework region 1) and
constant (C) region (constant region 1) cDNA template.
Additional file 3: Read statistics. Quality Phred scores, returned 250 bp
paired-end reads prior to PANDAseq pairing and IMGT annotation and
detected CDR3s/VDJs prior to application of various cutoffs (≥2 and reliability
cutoff established in Figure 3). For each cutoff, the total number of CDR3s/
VDJs (“All”) as well as respective “unique” CDR3s/VDJs (species richness) are
reported. Average numbers are reported as are the percentages of
CDR3s/VDJs that passed cutoffs compared to the total number of CDR3s/
VDJs. Percentages in brackets indicate (i) the ratio of PANDAseq-paired reads
out of the returned 250 bp reads (column: “Returned reads”), (ii) or the ratio
of CDR3s/VDJs out of the PANDAseq-paired reads (columns: “All CDR3s/
VDJs”). Replicate 2 (1M) and 3 (9M) have been used in simulations shown in
Figure 2.
Additional file 4: CDR3 repertoires from 1M were more polarized
than those from 9M and CDR3 repertoires were consistently more
polarized than VDJ repertoires (1M, 9M). The Berger-Parker index was
used to measure the polarization of repertoires [84] and is determined as
the ratio Nmax/N , where Nmax is the abundance of the top CDR3 or VDJ clone,
and N is the sum of abundances of all CDR3 or VDJ sequences in a replicate.
The index was calculated both for frequency distributions containing either all
CDR3 or VDJ clones with an abundance of 2 or higher and those CDR3 or
VDJ clones passing the reliability cutoff established in Figure 3.
Additional file 5: Frequency and cumulative frequency plots of
reliably detected CDR3 (A,B) and VDJ sequences (C,D) by replicate
and diversity scenario (1M, 9M) show an exponential distribution of
antibody repertoires. Relatively few different CDR3 or VDJ sequences
constitute a large part of sequencing reads. Reliable detection of CDR3
and VDJ sequences was established in Figure 3.
Additional file 6: CDR3 and VDJ sequence overlap among triplicate
sample. Venn diagrams were compiled based on reliably detected CDR3s
(A, B, C) and VDJs (D, E, F) for each scenario or respective mean
abundance distributions (1M/9M). Reliably detected CDR3 and VDJ
sequences were determined as detailed in Figure 3. Low overlap between
mean distributions (1M/9M) indicates minimal or no cross-contamination.
Mean distributions were determined by averaging the abundance of each
CDR3 or VDJ across replicates of a given diversity scenario (1M/9M).
Additional file 7: Triplicate correlation of CDR3 and VDJ
frequencies is high. CDR3 (A, B) and VDJ (C, D) frequencies were
Pearson correlated (r) among triplicates (CDR3: r ≥ 0.9926, VDJ: r ≥ 0.9871)
indicating the reproducibility of antibody repertoire sequencing. Only
reliably detected CDR3 and VDJ sequences (Figure 3) were considered for
the analysis shown.
Additional file 8: Quantile-Quantile (Q-Q) plots of triplicates show
that CDR3 frequency distributions (Additional file 5) are reproducible
across diversity scenarios. Q-Q plots (1M: A, B, C; 9M: D, E, F) represent a
graphical approach for comparing two frequency distributions by plotting
their quantiles against each other. If the two distributions being compared
are similar, the quantiles will lie on the indicated line. Only reliably detected
CDR3 sequences (Figure 3) were considered for the analysis shown.
Additional file 9: Quantile-Quantile (Q-Q) plots of triplicates show
that VDJ frequency distributions (Additional file 5) are reproducible
across diversity scenarios. Only reliably detected VDJ sequences (Figure 3)
were considered for the analysis shown (1M: A, B, C; 9M: D, E, F).
Additional file 10: Determination of reliability of CDR3 and VDJ
ranking. (A, B) Taking advantage of triplicate sequencing, coefficients of
variation (CV = SD/mean) based on ranks were determined for all reliably
detected CDR3 or VDJ clones (as determined in Figure 3) and plotted in
function of highest to lowest mean CDR3/VDJ frequency. CDR3/VDJ
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shown in red. Absolute numbers of reliably ranked clones are: CDR3,
730/4,160 (1M/9M), VDJ, 3,708/5,169 (1M/9M).
Additional file 11: Triplicate IgG amplicon libraries on 1% agarose
gel for (A) 1M and (B) 9M diversity scenarios. Libraries were prepared
each with cDNA equivalent to 500 ng of total pooled RNA of ASCs (see
Methods). 570-bp sized amplicons were gel-extracted and purified.
Legend: M – 100 bp DNA ladder.
Additional file 12: Bioanalyzer electropherograms of (A) one 1M
and (B) one 9M replicate after gel extraction. Single, clear peaks were
detected for all triplicates of both diversity scenarios (other replicates not
shown), resulting on average in 450/1,200 pg NGS-ready library for
1M/9M, respectively.
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